Both GLIS1 and NANOG have been indicated to activate certain components of the WNT pathway in reprogramming (Maekawa et al., 2011; Marucci et al., 2014), and WNT and LIN28 co-amplify the expression of their target genes in cancer cells (Tu et al., 2015). This evidence concerns the gene NANOG and cancer.